List view / Grid view
Shimadzu is celebrating 30 years as a leader in the development of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). This technology has become ubiquitous in analytical and clinical laboratories because of its versatility, ease of use, low operating costs and unique capabilities...
Improving the accuracy and user-friendliness of mass spec technologies to enable critical decisions in safety, healthcare and nutrition...
Easy-to-use software helps identify unknown compounds and extracts high-confidence understanding from complex mass spectra...
The 66th American Society for Mass Spectrometry (ASMS) Conference was held 03 - 07 June in San Diego, California.
Shimadzu Scientific Instruments (SSI) announces the release of the Nexera Mikros Microflow Liquid Chromatography Mass Spectrometry System. Covering the complete range from microflow to semi-microflow, this system allows operators to realize high sensitivity, yet with the reliability and ruggedness of HPLC...
Complete and easy-to-use LC-MS-based solution for biotherapeutics characterisation and quality testing...
Next-Generation UPLC Platform designed to keep pace with evolving laboratory requirements for chromatographic performance...
Supports development of analytical workflows to generate precise molecular profiles of patients...
Shimadzu Scientific Instruments (SSI) announces the release of the Cell Culture Media Analysis Platform, C2MAPTM-2000, a fully automated and integrated sample preparation workstation for the analysis of cell culture media...
New software offers improved workflow efficiency with enhanced data management and the tools to support 21 CFR Part 11 compliance across the SCIEX mass spectrometry portfolio...
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets...
Today, at the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics...
An international study has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease...
Researchers have developed a new biotech technique that promises to accelerate research into protein therapies...
The FDA has authorised the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalised patients...
